Tianjin Pharmaceutical Da Ren Tang reports no new developments in subsidiary bankruptcy case
SGX Filings
Sep 29
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said it has not observed any material changes in the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since its previous monthly update on Aug, 31 2026.
The company noted that it will continue to monitor the proceedings, liaise with the court-appointed administrator, and publish further monthly updates in line with Rule 704(23) of the Singapore Exchange Listing Manual. It also advised shareholders and potential investors to exercise caution when trading its shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.